ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
23 hedge funds and large institutions have $3.24M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
4% less funds holding
Funds holding: 24 → 23 (-1)
15% less capital invested
Capital invested by funds: $3.8M → $3.24M (-$559K)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$181K |
| 2 |
NPC
National Planning Corporation
El Segundo,
California
|
+$57.1K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$54K |
| 4 |
Morgan Stanley
New York
|
+$41.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$1.08M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$772K |
| 3 |
GCM
Goldman Capital Management
New York
|
-$249K |
| 4 |
CCI
Columbus Circle Investors
|
-$180K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$43K |
ECTE Hedge Fund Activity: Q3 2013 in Review
23 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q3 2013, worth a combined $3.24M — down 15% from $3.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ECTE and 5 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $181K. The largest seller was Knoll Capital Management, cutting an estimated $1.08M.
- 23 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q3 2013, down from 24 in Q2 2013.
- Funds reported $3.24M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q3 2013, down 15% quarter-over-quarter.
- 5 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q3 2013 and 6 closed out, a net change of -1 holder.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q3 2013 was Renaissance Technologies, an estimated $181K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q3 2013 was Knoll Capital Management, an estimated $1.08M sold.
Based on aggregated 13F filings for Q3 2013.